CQW Panacea-re-brand-rev3

Pharmacy

For the Week of April 20, 2015

Question:

Will Medicare pay for the new biosimilar Zarxio?

Answer:

Medicare Part B payment is now available and will be incorporated into the average sales price payment methodology. According to a recent memo issued by the Centers for Medicare & Medicaid Services, the approved biosimilar will be included in the next quarterly HCPCS tape release in the coming weeks, and it will appear in the claims processing system on July 1, 2015, effective retroactively to the Food & Drug Administration approval date of March 6, 2015.

Return to Compliance Question of the Week Index

BMQ3PR050515

Sign up to receive Compliance Question of the Week.

To view and archive of the Pharmacy Compliance Question fo the Week, click here